99 related articles for article (PubMed ID: 15627796)
1. Iron dextran causes renal iron deposition but not renal dysfunction in angiotensin II-treated and untreated rats.
Ishizaka N; Saito K; Noiri E; Sata M; Mori I; Ohno M; Nagai R
Nephron Physiol; 2004; 98(4):p107-13. PubMed ID: 15627796
[TBL] [Abstract][Full Text] [Related]
2. Iron overload augments angiotensin II-induced cardiac fibrosis and promotes neointima formation.
Ishizaka N; Saito K; Mitani H; Yamazaki I; Sata M; Usui S; Mori I; Ohno M; Nagai R
Circulation; 2002 Oct; 106(14):1840-6. PubMed ID: 12356639
[TBL] [Abstract][Full Text] [Related]
3. Iron chelation suppresses ferritin upregulation and attenuates vascular dysfunction in the aorta of angiotensin II-infused rats.
Ishizaka N; Saito K; Mori I; Matsuzaki G; Ohno M; Nagai R
Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2282-8. PubMed ID: 16100038
[TBL] [Abstract][Full Text] [Related]
4. Abnormal iron deposition in renal cells in the rat with chronic angiotensin II administration.
Ishizaka N; Aizawa T; Yamazaki I; Usui S; Mori I; Kurokawa K; Tang SS; Ingelfinger JR; Ohno M; Nagai R
Lab Invest; 2002 Jan; 82(1):87-96. PubMed ID: 11796829
[TBL] [Abstract][Full Text] [Related]
5. Role of aberrant iron homeostasis in the upregulation of transforming growth factor-beta1 in the kidney of angiotensin II-induced hypertensive rats.
Saito K; Ishizaka N; Aizawa T; Sata M; Iso-O N; Noiri E; Ohno M; Nagai R
Hypertens Res; 2004 Aug; 27(8):599-607. PubMed ID: 15492480
[TBL] [Abstract][Full Text] [Related]
6. Reduction of renal lipid content and proteinuria by a PPAR-γ agonist in a rat model of angiotensin II-induced hypertension.
Sakamoto A; Hongo M; Saito K; Nagai R; Ishizaka N
Eur J Pharmacol; 2012 May; 682(1-3):131-6. PubMed ID: 22387860
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II induces renal oxidant stress in vivo and heme oxygenase-1 in vivo and in vitro.
Haugen EN; Croatt AJ; Nath KA
Kidney Int; 2000 Jul; 58(1):144-52. PubMed ID: 10886559
[TBL] [Abstract][Full Text] [Related]
8. Heme oxygenase-1 is upregulated in the kidney of angiotensin II-induced hypertensive rats : possible role in renoprotection.
Aizawa T; Ishizaka N; Taguchi Ji; Nagai R; Mori I; Tang SS; Ingelfinger JR; Ohno M
Hypertension; 2000 Mar; 35(3):800-6. PubMed ID: 10720598
[TBL] [Abstract][Full Text] [Related]
9. Iron chelation and a free radical scavenger suppress angiotensin II-induced downregulation of klotho, an anti-aging gene, in rat.
Saito K; Ishizaka N; Mitani H; Ohno M; Nagai R
FEBS Lett; 2003 Sep; 551(1-3):58-62. PubMed ID: 12965205
[TBL] [Abstract][Full Text] [Related]
10. Administration of ANG II induces iron deposition and upregulation of TGF-beta1 mRNA in the rat liver.
Ishizaka N; Saito K; Noiri E; Sata M; Ikeda H; Ohno A; Ando J; Mori I; Ohno M; Nagai R
Am J Physiol Regul Integr Comp Physiol; 2005 Apr; 288(4):R1063-70. PubMed ID: 15604307
[TBL] [Abstract][Full Text] [Related]
11. Iron chelation and a free radical scavenger suppress angiotensin II-induced upregulation of TGF-beta1 in the heart.
Saito K; Ishizaka N; Aizawa T; Sata M; Iso-o N; Noiri E; Mori I; Ohno M; Nagai R
Am J Physiol Heart Circ Physiol; 2005 Apr; 288(4):H1836-43. PubMed ID: 15550525
[TBL] [Abstract][Full Text] [Related]
12. Iron and iron-handling proteins in the brain after intracerebral hemorrhage.
Wu J; Hua Y; Keep RF; Nakamura T; Hoff JT; Xi G
Stroke; 2003 Dec; 34(12):2964-9. PubMed ID: 14615611
[TBL] [Abstract][Full Text] [Related]
13. Hemin therapy attenuates kidney injury in deoxycorticosterone acetate-salt hypertensive rats.
Jadhav A; Torlakovic E; Ndisang JF
Am J Physiol Renal Physiol; 2009 Mar; 296(3):F521-34. PubMed ID: 19116243
[TBL] [Abstract][Full Text] [Related]
14. Differential induction of renal heme oxygenase and ferritin in ascorbate and nonascorbate producing species transfused with modified cell-free hemoglobin.
Butt OI; Buehler PW; D'Agnillo F
Antioxid Redox Signal; 2010 Feb; 12(2):199-208. PubMed ID: 19659432
[TBL] [Abstract][Full Text] [Related]
15. Different effects of angiotensin II and catecholamine on renal cell apoptosis and proliferation in rats.
Aizawa T; Ishizaka N; Kurokawa K; Nagai R; Nakajima H; Taguchi J; Ohno M
Kidney Int; 2001 Feb; 59(2):645-53. PubMed ID: 11168946
[TBL] [Abstract][Full Text] [Related]
16. V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reduction.
Perico N; Zoja C; Corna D; Rottoli D; Gaspari F; Haskell L; Remuzzi G
Kidney Int; 2009 Nov; 76(9):960-7. PubMed ID: 19625993
[TBL] [Abstract][Full Text] [Related]
17. DL-propargylglycine reduces blood pressure and renal injury but increases kidney weight in angiotensin-II infused rats.
Oosterhuis NR; Frenay AR; Wesseling S; Snijder PM; Slaats GG; Yazdani S; Fernandez BO; Feelisch M; Giles RH; Verhaar MC; Joles JA; van Goor H
Nitric Oxide; 2015 Sep; 49():56-66. PubMed ID: 26192363
[TBL] [Abstract][Full Text] [Related]
18. Prenatal exposure to lipopolysaccharide alters the intrarenal renin-angiotensin system and renal damage in offspring rats.
Hao XQ; Zhang HG; Yuan ZB; Yang DL; Hao LY; Li XH
Hypertens Res; 2010 Jan; 33(1):76-82. PubMed ID: 19911002
[TBL] [Abstract][Full Text] [Related]
19. Heme arginate therapy enhanced adiponectin and atrial natriuretic peptide, but abated endothelin-1 with attenuation of kidney histopathological lesions in mineralocorticoid-induced hypertension.
Ndisang JF; Jadhav A
J Pharmacol Exp Ther; 2010 Jul; 334(1):87-98. PubMed ID: 20392817
[TBL] [Abstract][Full Text] [Related]
20. Parenteral iron nephrotoxicity: potential mechanisms and consequences.
Zager RA; Johnson AC; Hanson SY
Kidney Int; 2004 Jul; 66(1):144-56. PubMed ID: 15200421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
